Page last updated on March 10, 2025
Lineage Cell Therapeutics, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2025-03-10 16:15:30 EDT.
Filings
10-K filed on 2025-03-10
Lineage Cell Therapeutics, Inc. filed a 10-K at 2025-03-10 16:15:30 EDT
Accession Number: 0000950170-25-036309
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Company Information
| Name | Lineage Cell Therapeutics, Inc. |
| CIK | 0000876343 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Ticker | LCTX - NYSE |
| Website | |
| Category | Non-accelerated filer Smaller reporting company |
| Fiscal Year End | December 30 |